Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

R
R Alles, Sascha

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Sascha R Alles
Favorite
Rades, Thomas

Copenhagen University
(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity
Thomas Rades
Favorite
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Thomas Rades
Favorite
Radmard, Ariana

Mercer University
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Ariana Radmard
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Ariana Radmard
Favorite
Radocea, Adrian

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Adrian Radocea
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Adrian Radocea
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Adrian Radocea
Favorite
Rafols, Clara

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Clara Rafols
Favorite
Rahimi, Shahnaz

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Shahnaz Rahimi
Favorite
Rahman, Aevelina

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Aevelina Rahman
Favorite
Rahman, Fahad Imtiaz

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Fahad Imtiaz Rahman
Favorite
Rahman, Mahbubur

North South University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mahbubur Rahman
Favorite
Rahman, Md Moshikur

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Md Moshikur Rahman
Favorite
Rahman, Md Nawabur

Square Pharmaceuticals Ltd.
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Md Nawabur Rahman
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Md Nawabur Rahman
Favorite
Rahman, Mohammad Asikur

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Mohammad Asikur Rahman
Favorite
Rahman, Mohammad Atiqur

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Mohammad Atiqur Rahman
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Mohammad Atiqur Rahman
Favorite
Rahman, Omar

Enable Injections
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Omar Rahman
Favorite
Rahman, Taufiq

University of Cambridge
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Taufiq Rahman
Favorite
Rahman, Ziyaur

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Ziyaur Rahman
Favorite
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Ziyaur Rahman
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Ziyaur Rahman
Favorite
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Ziyaur Rahman
Favorite
Rai, Anjali

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Anjali Rai
Favorite
Rainey, Trevor

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Trevor Rainey
Favorite
Rainville, Paul D.

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Paul D. Rainville
Favorite
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Paul D. Rainville
Favorite
Raitsin, Sofia

Biopharma Services Inc.
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Sofia Raitsin
Favorite
Rajaii, Fatemeh

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Fatemeh Rajaii
Favorite
Rajapaksha, Ruwini

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Ruwini Rajapaksha
Favorite
Raje, Vishvesh

St. John's University
(M0930-09-48) Data-Driven Prediction of Translational Formulation Strategies for Poorly Water-Soluble Drug Molecules: Machine Learning to Minimize Trial and Error in Early Formulation Development
Vishvesh Raje
Favorite
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Vishvesh Raje
Favorite
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Vishvesh Raje
Favorite
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Vishvesh Raje
Favorite
Ramakrishnan, Abira

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Abira Ramakrishnan
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Abira Ramakrishnan
Favorite
Ramakrishnan, Radha

Bristol Myers Squibb
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Radha Ramakrishnan
Favorite
Ramakrishnan, Yogaraj

North Dakota State University
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Yogaraj Ramakrishnan
Favorite
Ramani, Ashish

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Ashish Ramani
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Ashish Ramani
Favorite
Ramezanli, Tannaz

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Tannaz Ramezanli
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Tannaz Ramezanli
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Tannaz Ramezanli
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Tannaz Ramezanli
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Tannaz Ramezanli
Favorite
Ramisetty, Bhargavi Srija

University of Kansas
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Bhargavi Srija Ramisetty
Favorite
Ramos, Corinne

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
Corinne Ramos
Favorite
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Corinne Ramos
Favorite
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Corinne Ramos
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Corinne Ramos
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Corinne Ramos
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Corinne Ramos
Favorite
Ramos, Ines

Hovione
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Ines Ramos
Favorite
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Ines Ramos
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Ines Ramos
Favorite
Rana, Sohel

Jahangirnagar University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Sohel Rana
Favorite
Ranathunga, Dineli

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Dineli Ranathunga
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Dineli Ranathunga
Favorite
Rane, Manish

Evonik Corporation
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Manish Rane
Favorite
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
Manish Rane
Favorite
Rane, Rahul

SOPAT
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Rahul Rane
Favorite
Raney, Sam

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Sam Raney
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Sam Raney
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Sam Raney
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Sam Raney
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Sam Raney
Favorite
Rangappa, Srinath

Topical Products Testing
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Product Testing LLC
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Products Testing
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Srinath Rangappa
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Product Testing LLC
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Srinath Rangappa
Favorite
Rangari, Vijaya

Tuskegee University
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Vijaya Rangari
Favorite
Ranjbar, Sheyda

University of Connecticut
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Sheyda Ranjbar
Favorite
Ransdell-Green, Eleanor

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Eleanor Ransdell-Green
Favorite
Rasamoelisolo, Michele

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Michele Rasamoelisolo
Favorite
Rascon, Adriana

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Adriana Rascon
Favorite
Rasmussen, Quinn

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Quinn Rasmussen
Favorite
Rasulo, Nick

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Nick Rasulo
Favorite
Rathod, Drishti

St. John's University
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Drishti Rathod
Favorite
(W1230-03-18) Harnessing Albumin-Anchored BRD4 PROTAC Nanoliposomes for Selective and Targeted Degradation in Pancreatic Ductal Adenocarcinoma
Drishti Rathod
Favorite
Rathore, Anurag

Indian Institute of Technology
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Anurag Rathore
Favorite
Rath, Seeprarani

Rutgers, The State University of New Jersey
(T1230-02-10) Revisiting Potency Classification of Topical Corticosteroids Using a Standardized Approach Involving Vasoconstrictor Assay (VCA)
Seeprarani Rath
Favorite
Rautenberg, Annika

University of Bonn
(W1030-11-63) Crystalline Craftsmanship: Controlling Surface Roughness of Spray-Freeze-Dried Particles
Annika Rautenberg
Favorite
Raut, Nishikant

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Nishikant Raut
Favorite
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Nishikant Raut
Favorite
Ravenhill, Dannielle

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Dannielle Ravenhill
Favorite
Ravikumar, Tarini

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Tarini Ravikumar
Favorite
Rawal, Saurin

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Saurin Rawal
Favorite
Rawa, Susan

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Susan Rawa
Favorite
Rayaprolu, Bindhu

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Bindhu Rayaprolu
Favorite
Ray, Michael

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Michael Ray
Favorite
Razack, Nihala

Fairleigh Dickinson University
(M1230-05-25) A Molecular Dynamics Study of the Impact of Water Content on Pre-nucleation Aggregates in Amorphous 2-Phenylamino Nicotinic Acid
Nihala Razack
Favorite
Rebola, Teresa

Hovione
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Teresa Rebola
Favorite
Reddy, Sravani

St. John's University
(M1030-09-52) Development of a Self-Emulsifying Drug Delivery System (SEDDS) of Fenofibrate Using ZoomLab^TM
Sravani Reddy
Favorite
Reese, Kimberly

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Kimberly Reese
Favorite
Refaat, Hesham

University of Iowa
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Hesham Refaat
Favorite
Rege, Bhagwant

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Bhagwant Rege
Favorite
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Bhagwant Rege
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Bhagwant Rege
Favorite
Reginauld, Bianca

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Bianca Reginauld
Favorite
Reichel, Felix

Heinrich Heine University Düsseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Felix Reichel
Favorite
(T1230-02-09) Examination of the Diffusion Properties of Hydrogels as Optimized Preclinical In Vitro Models for the Human Vitreous Body
Felix Reichel
Favorite
Reich, Jeffrey

Sparian Biosciences
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Jeffrey Reich
Favorite
Reil, Eric

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Eric Reil
Favorite
Reines, Scott

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Scott Reines
Favorite
Ren, Angela

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Angela Ren
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Angela Ren
Favorite
Ren, Ke

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Ke Ren
Favorite
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Ke Ren
Favorite
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
Ke Ren
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Ke Ren
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Ke Ren
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Ke Ren
Favorite
Rennier, Keith

LabCorp
(M0930-10-59) Validation of a Quantitative PCR (qPCR) Assay for the Detection and Quantification of Replication Competent Lentivirus for Patient Monitoring in Lentiviral Vector-Based Cell Therapy Studies
Keith Rennier
Favorite
Ren, Ning

WuXi AppTec Co., Ltd./ DMPK (NJ, USA)
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Ning Ren
Favorite
Ren, Yi

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Yi Ren
Favorite
Ren, Zhongjie

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Zhongjie Ren
Favorite
Repka, Michael

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Michael Repka
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Michael Repka
Favorite
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Michael Repka
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Michael Repka
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Michael Repka
Favorite
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Michael Repka
Favorite
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Michael Repka
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Michael Repka
Favorite
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Michael Repka
Favorite
Reppas, Christos

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Christos Reppas
Favorite
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Christos Reppas
Favorite
Reumer, Ank

Nelson Labs
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Ank Reumer
Favorite
Reynolds, Thomas

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Thomas Reynolds
Favorite
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Thomas Reynolds
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Thomas Reynolds
Favorite
Rezhdo, Oljora

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Oljora Rezhdo
Favorite
Reznik, Sandra

St. John's University
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Sandra Reznik
Favorite
Richardson, Norman

BASF Corporation
(M1230-09-51) Formulating Sustainable Solid Oral Tablets by Employing Digital Tools and Co-Processed Excipients
Norman Richardson
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Norman Richardson
Favorite
Richards, Terjahna

St. John's University
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Terjahna Richards
Favorite
Ridgway, Jake

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jake Ridgway
Favorite
Riemann, Bernadette

University of Bonn
(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles
Bernadette Riemann
Favorite
Rieutord, André

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
André Rieutord
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
André Rieutord
Favorite
Rios-Alegre, Adriana

Universidad Autonoma Del Estado De Morelos
(M1330-04-22) In Silico Evaluation of Coumarin Derivatives as Potential Antioxidant Agents on Psoriasis Treatment
Adriana Rios-Alegre
Favorite
Rioux, Nathalie

Certara UK Ltd
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Nathalie Rioux
Favorite
Ritchie, Stuart

Adare Pharma Solutions
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Stuart Ritchie
Favorite
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
Stuart Ritchie
Favorite
Rivera-Islas, Jesus

Universidad Autonoma Del Estado De Morelos
(M1330-04-22) In Silico Evaluation of Coumarin Derivatives as Potential Antioxidant Agents on Psoriasis Treatment
Jesus Rivera-Islas
Favorite
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Jesus Rivera-Islas
Favorite
Rivera-Leyva, Julio Cesar

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Julio Cesar Rivera-Leyva
Favorite
Rivera, Shannon

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Shannon Rivera
Favorite
Robart, Stephanie

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Stephanie Robart
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Stephanie Robart
Favorite
Roberts, Frederick

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Frederick Roberts
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Frederick Roberts
Favorite
Roberts, Michael

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Michael Roberts
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Michael Roberts
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Michael Roberts
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Michael Roberts
Favorite
Robin, Marianne

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Marianne Robin
Favorite
Robinson, Lindsay

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Lindsay Robinson
Favorite
Robinson, Morgan

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Morgan Robinson
Favorite
Robota, Miriam

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Miriam Robota
Favorite
Rochet, Jean

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Jean Rochet
Favorite
Rodriguez Maciñeiras, Xela

FABRX Ltd
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Xela Rodriguez Maciñeiras
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Xela Rodriguez Maciñeiras
Favorite
Rodrigues, Liliana

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Liliana Rodrigues
Favorite
Rodriguez, Alexander

PPD, a part of Thermo Fisher Scientific
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Alexander Rodriguez
Favorite
Rodriguez-Cruz, Vivian

Eli Lilly and Company
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Vivian Rodriguez-Cruz
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Vivian Rodriguez-Cruz
Favorite
Rogers, True

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
True Rogers
Favorite
Rojas, Sofia

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Sofia Rojas
Favorite
Romanova, Svetlana

University of Nebraska Medical Center
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
Svetlana Romanova
Favorite
Romanski, Michal

Poznan University of Medical Sciences
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Michal Romanski
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Michal Romanski
Favorite
Ronaldson, Patrick

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Patrick Ronaldson
Favorite
Rooney, Melissa

DigiM Solution LLC
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Melissa Rooney
Favorite
Rosalas Soto, Jesus

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Jesus Rosalas Soto
Favorite
Roscoe, Ben

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Ben Roscoe
Favorite
Rostami-Hodjegan, Amin

Certara UK Ltd.
(W1130-02-12) Virtual Bioequivalence (VBE) Outcome May Depend on Choice of Dissolution Inputs in Physiologically Based Pharmacokinetic Modelling
Amin Rostami-Hodjegan
Favorite
Rotello, Vincent

University of Massachusetts
(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation
Vincent Rotello
Favorite
(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
Vincent Rotello
Favorite
Roundtree, Imani

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Imani Roundtree
Favorite
Rowe, Blake

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Blake Rowe
Favorite
Roy, Mckenzie

University of Connecticut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Mckenzie Roy
Favorite
Roy, Sourav

University of Texas El Paso
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Sourav Roy
Favorite
Ruhn, Peggy

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Peggy Ruhn
Favorite
Ruiz, Rebeca

Pion Inc. (UK) Ltd
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Rebeca Ruiz
Favorite
Rumbelow, Stephen

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
Stephen Rumbelow
Favorite
Russo, Jackson

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Jackson Russo
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Jackson Russo
Favorite
Ryan, Callum

University College Cork
(W1030-04-21) Computational Pharmaceutics Approaches to Guide Lipid Based Formulation Development: How Data Mining Can Improve the Process
Callum Ryan
Favorite
Ryman, Josiah

EMD Serono
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
Josiah Ryman
Favorite